Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, February 22, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Regulatory Affairs
Regulatory Affairs
Regulatory Affairs
Drug Approval Process in China
admin
-
January 19, 2020
Regulatory Affairs
Approval pathways of Fixed dose combination (FDC) in India
admin
-
January 12, 2020
Regulatory Affairs
Drug Approval Process in India
admin
-
January 4, 2020
Regulatory Affairs
Orphan Drug Designation in US, EU and Japan
admin
-
December 31, 2019
Regulatory Affairs
The Drug approval process in EU:
admin
-
December 29, 2019
Regulatory Affairs
Biologics Approval Pathways in the USA:
admin
-
December 27, 2019
0
Regulatory Affairs
Generic Products Approval Pathways (USA): Paragraph Certification I, II, III, and IV:
admin
-
December 25, 2019
0
Regulatory Affairs
Drug Approval process-FDA
admin
-
December 21, 2019
2
Regulatory Affairs
Medical Device Registration in Japan-Todokede, Ninsho and Shonin Pathways
admin
-
November 23, 2019
0
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025